Select a medication above to begin.
Mepsevii (vestronidase alfa-vjbk)
vestronidase alfa
Black Box Warnings .
Anaphylaxis
anaphylactic reactions reported as early as 1st dose; should only be administered by healthcare professional prepared for anaphylaxis management; observe patients during tx and x60min after administration; D/C tx immediately if anaphylaxis signs/symptoms
Adult Dosing .
Dosage forms: INJ
Special Note
- [drug name clarification]
- Info: nonproprietary name = vestronidase alfa-vjbk
mucopolysaccharidosis VII
- [4 mg/kg/dose IV q2wk]
- Info: premed with non-sedating antihistamine, consider antipyretic
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: INJ
Special Note
- [drug name clarification]
- Info: nonproprietary name = vestronidase alfa-vjbk
mucopolysaccharidosis VII
- [4 mg/kg/dose IV q2wk]
- Info: premed with non-sedating antihistamine, consider antipyretic
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]